BIOMAT Database Logo BIOMAT Database Logo

Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors. 2015

Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University.

A series of aryl-2H-pyrazole derivatives were synthesized and evaluated for inhibitory activity against xanthine oxidase in vitro as potent xanthine oxidase inhibitors. Among them, 2 aryl-2H-pyrazole derivatives showed significant inhibitory activities against xanthine oxidase. Compound 19 emerged as the most potent xanthine oxidase inhibitor (IC50=9.8 µM) in comparison with allopurinol (IC50=9.5 µM). The docking study revealed that compound 19 might have strong interactions with the active site of xanthine oxidase. This compound is thus a new candidate for further development for the treatment of gout.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014969 Xanthine Oxidase An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. Hypoxanthine Oxidase,Hypoxanthine Dehydrogenase,Hypoxanthine-Xanthine Oxidase,Purine-Xanthine Oxidase,Dehydrogenase, Hypoxanthine,Hypoxanthine Xanthine Oxidase,Oxidase, Hypoxanthine,Oxidase, Hypoxanthine-Xanthine,Oxidase, Purine-Xanthine,Oxidase, Xanthine,Purine Xanthine Oxidase
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
February 2013, Bioorganic & medicinal chemistry letters,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Design and synthesis of chalcone derivatives as potential non-purine xanthine oxidase inhibitors.
January 2016, SpringerPlus,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition.
February 2021, Bioorganic chemistry,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors.
October 2012, Bioorganic & medicinal chemistry,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Synthesis and biological evaluation of thiazolidine-2-thione derivatives as novel xanthine oxidase inhibitors.
January 2022, PloS one,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.
April 2008, European journal of medicinal chemistry,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
June 1996, Journal of medicinal chemistry,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
[Design, synthesis and biological evaluation of oxadiazole derivatives as xanthine oxidase inhibitors].
June 2016, Yao xue xue bao = Acta pharmaceutica Sinica,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
May 2019, Bioorganic chemistry,
Zhi-Gang Sun, and Xiao-Jing Zhou, and Ming-Li Zhu, and Wen-Ze Ding, and Zhen Li, and Hai-Liang Zhu
Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors.
September 2014, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!